Insider · CIK 0001654337
Kamil Ali-Jackson
director
Files at RIGL (RIGEL PHARMACEUTICALS INC), PDSB (PDS Biotechnology Corp). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2025 | PDSB PDS Biotechnology Corp | AGrant or award Employee Stock Option (Right to Buy)derivative | +22,700 | $0.00 | $0 | 22,700 | Jun 11, 2025 |
| May 23, 2025 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Common Stock | +2,500 | $0.00 | $0 | 9,375 | May 28, 2025 |
| May 23, 2025 | RIGL RIGEL PHARMACEUTICALS INC | AGrant or award Stock Option (Right to Buy)derivative | +3,000 | $0.00 | $0 | 3,000 | May 28, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.